Perrigo Company plc today announced that, Valeant Pharmaceuticals North America LLC, Valeant Pharmaceuticals Ireland LTD., Dow Pharmaceuticals Sciences, Inc., and Kaken Pharmaceuticals Co., LTD, initiated patent litigation on September 21, 2018 in the United States District Court for the District
October 1, 2018
· 5 min read